Pacira Touts Stability Upgrade In Pain Drug Patent Trial
A novel manufacturing process that extends the shelf life of the pain reliever Exparel should extend the exclusivity period of the product's patent, Pacira BioSciences Inc. has told a New Jersey...To view the full article, register now.
Already a subscriber? Click here to view full article